Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Shandong Loncom Pharmaceutical Co., Ltd., established in May 2012, spans 15 hectares with a registered capital of USD 10 million and a planned total investment of USD 35 million. Focused on new drug development, it has evolved into a modern high-tech pharmaceutical enterprise integrating R&D, services, production, and marketing in line with advanced GMP standards from Europe, the U.S., and Japan. The company aims to build a le...
Shandong Loncom Pharmaceutical Co., Ltd., established in May 2012, spans 15 hectares with a registered capital of USD 10 million and a planned total investment of USD 35 million. Focused on new drug development, it has evolved into a modern high-tech pharmaceutical enterprise integrating R&D, services, production, and marketing in line with advanced GMP standards from Europe, the U.S., and Japan. The company aims to build a leading API pilot plant, production facilities, and a comprehensive pharmaceutical industrial park for new drug R&D, manufacturing, and distribution.

List your booth number for exhibitions, ask us